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Abstract
In 1983 the sentinel laboratory network was established because of the need to describe
the epidemiological evolution of infectious diseases. During the study period of 30 years
(1983–2013), microbiology laboratories reported on weekly basis the laboratory diagnosed
cases for a selection of infectious diseases. This resulted in a large longitudinal laboratory
based database allowing to provide trends over time and distribution by person and place.
During this period, adaptations to data collection were made due to changes in diagnostic
methods and public health priorities, introduction and application of digital revolution, and
multiple reorganizations of the laboratories. Since the surveillance network is dynamic, it
necessitates a continuous evaluation to ensure that, over time, it continues to be represen-
tative of the general epidemiological trends in the country. Secondly the aim is to examine
the robustness and stability of this surveillance system. Here we demonstrated that the flex-
ibility of the data collection methodology by the sentinel laboratory network is unique and
that adaptations do not affect the capacity of the system to follow trends. Therefore, the sur-
veillance by this network is representative of the current epidemiological situation in Bel-
gium. To our knowledge, no such surveillance network with such a long-term follow-up and
demonstrated stability for multiple infectious diseases in the general population was earlier
described. Furthermore, expected trends due to the implementation of vaccination or other
events were accurately detected. The collected data obtained from this network allows inter-
esting comparisons with other national and international information sources.
Introduction
In Belgium, the sentinel laboratory network was established in 1983 in order to obtain informa-
tion on the epidemiology of infectious diseases [1]. The laboratories participating to this net-
work are further called the sentinel laboratories.
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This sentinel laboratory network is coordinated by the Scientific Institute of Public Health
(WIV-ISP) organizing the data collection and data storage, and facilitating the data processing
and dissemination of this information.
The main objective of this network is to monitor the evolution of different infectious dis-
eases over time, both within a calendar year and over several years. The collected information
allows as well to fulfil national and international (i.e. ECDC, WHO) requests.
Next to this sentinel laboratory network, other surveillance networks for human infectious
diseases, complementing each other, are available in Belgium, i.e. the notification of infectious
diseases organised by the Flemish Community [2], Brussels Capital and the French-speaking
Community [3], the network of paediatrics collecting mainly data on vaccine preventable
infectious diseases in children since 2002 [4], the network for surveillance of sexually transmit-
ted diseases since 2000 [5], the network of national reference laboratories and the national ref-
erence centers collecting public health microbiology data since 2011 (see also materials and
methods) [6] and the registration network of general practitioners since 1979 [7]. Each surveil-
lance system has its strengths and weaknesses.
Although the mandatory notification system and the sentinel laboratory network are both
fed by microbiology laboratories, additional clinical information is provided to the mandatory
notification system by the treating physicians which renders this system exhaustive. On the
other hand, the sentinel laboratory network is based on a fraction of the microbiology laborato-
ries raising concerns about the representativeness nationwide and regional [8].
By monitoring 12 pathogens, it was previously demonstrated [9,10] that the coverage of the
sentinel network was stable over time and close to, or greater than 50%. Test coverage was in
this study calculated by the ratio of reimbursed tests performed by participating laboratories to
the total number of tests performed. These results indicate that the network is sensitive and
representative for the surveillance of the selected pathogens. Furthermore, these results hold
for the 3 regions of Belgium but at the provincial level, a lower test coverage was shown for
some pathogens [10]. Moreover, the information provided by the sentinel network is usually
considered to be timelier and more complete due to a better compliance of voluntary reporting
laboratories [8].
This paper describes the historic changes and developments of the Belgian sentinel labora-
tory network such as the flexibility of adaptation of the network towards pathogen changes,
diagnostic method changes, data transfer methodology and multiple reorganization of the par-
ticipating sentinel laboratories. The lack of impact of these changes on the robustness of the
longitudinal surveillance of this network was investigated by a detailed description of the trend
changes for a series of infectious diseases.
Materials and Methods
Organisation of the network
The sentinel laboratory network was implemented from 1983 onwards as described previously
by Walckiers et al. (1991) [1]. Briefly, microbiology laboratories transferred on a weekly basis
their laboratory diagnosed cases to the WIV-ISP on paper form by regular mail. The informa-
tion for a limited number of variables was collected for a selection of infectious diseases. The
encoded variables included the diagnosed infectious disease, some patients demographic data
allowing the identification of duplicates i.e. date of birth (or previously age), gender and postal
code. In addition the specimen and its sample identification number, the diagnostic method
and the date of diagnosis are recorded as well. If applicable, the registration of the country of
infection is foreseen. For confidence reasons, all data transfers are kept anonymous towards
the patient.
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All data were collected in a central database and analysed for a quarterly and annual report.
The participation by the sentinel laboratories was and is still today voluntary and without
remuneration.
If requested by a dedicated reference laboratory, the sentinel laboratories are encouraged to
send strains to the reference laboratories/centers for further characterisation such as geno-
and/or phenotyping or antimicrobial follow-up.
The project on sentinel laboratory network is scientifically supervised by a steering commit-
tee composed by representatives of the sentinel laboratories, reference laboratories/centers and
authorities from the Flemish Community, Brussels Capital and the French-speaking Commu-
nity having infection control and prevention into their competencies.
The list of infectious diseases is yearly reviewed by this steering committee selecting patho-
gens based on the current need of public health.
In 2013, the trend analysis included 35 pathogens and covered respiratory infections, gastro-
intestinal infections, sexually transmitted infections, imported infections as well as zoonosis
and vaccine preventable diseases [11]. The list of pathogens is chosen such that it does not
overburden the administrative work for the sentinel laboratories.
Study period
The impact of historical adaptations during the study period of 30 years, starting from the
implementation of the project (1983) until 2013, were recorded and described.
Historical adaptations to improve the functioning of the network
During the study period, the network underwent several adaptations according to the evolution
at the level of microbial diagnosis and due to the digital revolution. A summary of all adapta-
tions is briefly described underneath.
Since the implementation of the network, the diagnosticmethods were yearly revised. As of
1983 all data covered culture positive cases for the 26 infectious diseases. Meanwhile cases diag-
nosed by serological methods were included gradually since 1987, those by molecular diagnosis
(PCR) gradually since 2004 and currently the molecular diagnosis is included for 31 out of the
36 infectious diseases.
The weekly transfer of data from the laboratories to the WIV-ISP was initially on paper for-
mat. Since the beginning of 2000, some of the laboratories were able to extract the needed
information directly from their databases. These cases were recorded in batch to the database.
During the same period, other laboratories reported their data via a web application, developed
and made available by the WIV-ISP. An online submission tutorial was provided to the partici-
pating laboratories extracting their data from their laboratory information management system
(LIMS) or those reporting by the webtool. As further described in the results section, the frac-
tions of data obtained by the different data transfer methods by the participating sentinel labo-
ratories changed during the last few years. All historical datasets obtained by the different data
transfer methods were collected on a SQL server at the public health institute WIV-ISP for fur-
ther data cleaning.
Since the microbiology laboratory test results populating the database throughout all these
years are neither uniformly coded nor documented in a standardized manner, some quality
assurance measurements were taken. The application of a systematic approach was introduced
since 2009 by the definition of harmonized variables and their formats including well defined
own coded values [11]. This was felt necessary for an ongoing oversight and a management of
the database to remain valid and useful. All procedures were described in standard operating
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procedures (SOP) and are available in the internal document management system (not shared
in public but available on request).
A number of quality checks were gradually implemented to improve the completeness and
correctness of the reported cases in the database.
Firstly, the completeness of the recorded cases reported by paper format was double checked
by a second person.
Secondly, a monthly feedback was sent since 2012 to all sentinel laboratories to provide an
overview of all transferred data since the beginning of the current year. This feedback allows
the participating laboratories to determine the completeness of their data in the database and
moreover to compare the rate of diagnosed infectious diseases of their laboratories with those
from all participating laboratories. This feedback system allows to receive the missing data
from the participating laboratories and improving thereby the completeness of the data.
Lastly, quality checks toward variable completeness, consistency, content, alignment with
specifications (case definitions), expected trends (seasonal and yearly) are performed on weekly
basis for a few cases, selected by cherry picking from all received data.
Recently case definitions for each of the infectious diseases were defined [11] based on
available international information [12,13] to harmonise the inclusion of cases and to ensure
their fulfilment of the case criteria.
The availability of reference laboratories collaborating with this network on a voluntary
basis was since 2011 replaced partially by a network of National Reference Centers (NRC’s)
[6]. These NRC’s were selected based on defined criteria, are reimbursed for their activities and
need to fulfil to the proper quality assurance level (ISO15189). The tasks of these laboratories
and NRC’s are to diagnose or to confirm rare diseases or diseases difficult to diagnose, to per-
form some further typing of strains, to determine the resistance towards antimicrobials or their
resistance mechanisms and finally provide these epidemiological and microbial data for report-
ing at national and international levels.
Data cleaning
The definition of the variables and their formats allowed assembling all historical data into one
database on which longitudinal trend analysis can be performed.
Since 2012, a data cleaning program was implemented with SAS software (SAS Institute
Inc.1, Cary, NC, USA). The program mainly executes the following steps: append all historical
tables, harmonize variable names and their format, compute new variables (i.e. age, agegroup),
and remove duplicates on basis of sample identification or patient demographic data i.e. date
of birth (or previously age), gender and postal code.
The encoded variables included the diagnosed infectious disease, some patient’s demo-
graphic data and specimen and analysis method information.
This clean table is optimised by statistical programs and is automatically updated twice a day.
Data analysis
A web platform called “Epistat” (https://epistat.wiv-isp.be/) was built since 2012 for secured
feedback and real time analysis of the clean database. This platform allows the construction of
different types of graphs for epidemiological monitoring and for further investigations according
to the needs of the sentinel laboratories and other stakeholders: time distributions, geographical
maps, age pyramids, pie charts and histograms. Created graphs may be used in surveillance
reports and scientific publications by both the WIV-ISP and the sentinel laboratories.
The tool is composed of three different parts: a webform, written in HTML5 and Javascript; a
SAS program (SAS Institute Inc.1, Cary, NC, USA) generating the different options appearing
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in the form; and a SAS stored process receiving the selected options in the form and creating the
final output in the browser window. Since the software runs on the web, the application is acces-
sible only with an internet connection and a browser. Access to this application is restricted to
the participating laboratories, the WIV-ISP staff members and the officers from the health
authorities with logins and passwords.
Results
Laboratory participation rate
During the study period, the number of participating laboratories has decreased over time (Fig
1A). After a first introduction period of the network, 159 laboratories participated to the sur-
veillance in 1985 and currently we observed 97 sentinel laboratories in 2013. However due to
structural reorganizations and fusions of some clinical laboratories, the ratio of participating
sentinel laboratories from all microbiology laboratories has increased from 40% in 1985 to 58%
in 2004 and remained constant since then (Fig 1B). In 2013, the fraction of participating labo-
ratories on the total number of registered microbiology laboratories in Belgium was 59% (97
participating laboratories out of 163 microbiology laboratories). We could not determine
whether the academic and non-academic hospital related laboratories, and non-hospital
related laboratories participating to the network are proportionally representative from the lab-
oratories performing microbiological diagnoses in Belgium.
However, the coverage, a measure of the proportion of target population included in the
surveillance system was previously studied [9, 10] demonstrating that the participating labora-
tories were performing more than 50% of all tests, and that the coverage was constant in Bel-
gium between 1999 and 2002 [9] and between 2007 and 2012 [10].
In 2013, the distribution of sentinel laboratories by region was 54% in the Flemish Commu-
nity, 34% in the French-speaking Community and 12% in Brussels Capital. This distribution is
comparable to that of all the registered microbiology laboratories in Belgium (data not shown)
demonstrating its regional representativity. Also the distribution of the Belgian population
(n = 11.099.554 in 2013) is similar: 57% in the Flemish Community, 32% in the French-speak-
ing Community and 10% in Brussels Capital.
Evolution in Number of Pathogens and Data Transfers
The number of infectious diseases for which data were collected, increased from 26 in 1983 to
the currently 35.
A gradual increase of the number of reported cases was observed during the study period of
30 years (data not shown). Especially during the last decade when the digital data transfer
became available, a tremendous increase of the number of reported cases was observed (Fig 2).
The availability of a digital data transfer system reduced the workload substantially and
improved the speed of data transmission. However, this necessitates the availability of an auto-
matically process to clean the data especially removing the duplicates. As demonstrated further,
the implementation of digital data transfer improved the completeness of the data without
impact on the number of cases after removal of duplicates.
In 2013 only 12 laboratories (12%) used the paper form to report their data.
Long standing follow-up of infectious diseases
For 10 infectious diseases (Campylobacter, Chlamydia trachomatis, Entamoeba histolitica,Hae-
mophilus influenzae, Legionella pneumophila, Neisseria gonorrhoeae, N.meningitidis, Plasmo-
dium, Streptococcus pneumoniae, and Yersinia enterocolitica), the surveillance covered the
30 Years of Surveillance of Infectious Diseases by the Sentinel Laboratory Network
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Fig 1. Number of sentinel laboratories participating to the sentinel laboratory network (A) and
percentage of microbiology laboratories participating to the network as compared to the total number
of registeredmicrobiology laboratories (B).
doi:10.1371/journal.pone.0160429.g001
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entire study period of 30 years. Fig 3 demonstrates the yearly trend analysis for some of these
including the seasonal activities. Although for Yersinia enterocolitica a continuous decrease
was observed since 1983, the Campylobacter surveillance demonstrated a continuous number
of reported cases. Within this waving incidence over the years (slight increase till 2000 followed
by a decrease and relapse again from 2010 onwards), we observed a seasonal decrease in sum-
mer 1999. During the same period, the contamination of feedstock with polychlorinated biphe-
nyls was demonstrated leading to the destruction of massive amounts of animal food products,
mainly eggs and chicken [14]. This so called dioxin affair led to the reduced consumption of
these animal food products and thereby a significant decline (40%) in the number of infections
[15].
For the follow-up of the sexual transmitted infections (STI), a continuous increase is
observed as demonstrated in Fig 3 for C. trachomatis and N. gonorrhoeae without notification
of a similar increase of reimbursed tests [10]. For C. trachomatis (in 2001: N = 775, in 2013:
N = 5232) the number of cases in the age range of young women from 15 to 29 years explains
largely the increase, while for N. gonorrheae (in 2001: N = 230, in 2013: N = 1063) the increase
is situated in particular in men from 20 to 34 years and for T. pallidum (in 2002: N = 114, in
2013: N = 1293), the increase is situated in particular in men from 35 to 49 years old. These
Fig 2. Number of reported cases before removal of the duplicates from 2007 when the digital data transfer became available until 2013. The total
number of reported cases (Total) is transferred by sending the information on paper format by regular mail (Paper), by importing the cases via a web
application developed by the WIV-ISP (WebForm), or by sending an extraction of the cases from the laboratory information management system (Export).
doi:10.1371/journal.pone.0160429.g002
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increases are mainly observed in the Flemish Community (district of Antwerp) and in Brussels
Capital (data not shown). These evolutions are also observed in other European countries [16].
It is also necessary to remain vigilant watchful as for the evolution of the used techniques of
diagnosis to explain our observations. For example, the development since 2002 of more sensi-
tive techniques of diagnosis could partially explain the increased diagnosis of sexual transmit-
ted infections. However, the implementation of a clinical STI network confirmed the increase
of STI [17].
Fig 3. Trend analyses for some representative infectious diseases as measured by the sentinel laboratory network from 1993 (if available)
until 2013. The dashed line represents the monthly number of cases while the orange line represents a smoothed curve obtained by the Loess
statistical method (SAS Institute Inc.1, Cary, NC, USA), a weighted scatterplot through these data points. Campylobacter, Y. enterocolitica,
Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus influenzae, Neisseria meningitidis, Borrelia burgdorferi, Rotavirus, and RSV.
doi:10.1371/journal.pone.0160429.g003
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For Haemophilus influenzae and Neisseria meningitidis, a sudden decrease was observed
from 2002 onwards. This could be brought in relation with the introduction and/or the reim-
bursement policy of the vaccines against these infectious diseases. For Neisseria meningitidis, a
drop from 280 cases in 2001 to 108 cases in 2013 was observed. The reference laboratory/center
for Neisseria meningitidis receiving the strains for further subtyping, demonstrated the
decrease in incidence of serogroup C from 49.4% in 2001 to 10.4% in 2013 [18] showing that
the N.meningitidis serogroup C was brought under control.
For 11 other pathogens (Borrelia burgdorferi, Bordetella, Chlamydia psittaci, Cryptosporid-
ium, Giardia, Hantavirus, Hepatitis A virus, Influenza,Mycoplasma pneumoniae, Streptococcus
pyogenes, and VTEC), a surveillance is available spanning a period of more than 20 years. The
trend analysis and other surveillance systems are described in details in the annual reports and
are available on the website of the network (https://epidemio.wiv-isp.be).
The serological confirmation of Borrelia burgdorferi, to diagnose Lyme borreliose, is also
included in the surveillance program from the beginning of the years '90. Between 1998 and
2012 the incidence raised reaching yearly between 1000–1500 cases. Within the period 2007–
2012, respectively 120.000 to 280.000 tests were performed per year [10]. Since then, due to
multiple discussion forums concerning the so called ‘chronic Lyme disease’ or post-treatment
Lyme disease syndrome and an increased interest by the media of the Lyme disease in Belgium,
the reported cases increased to 2090 in 2013. Also an increased test frequency was demon-
strated during this period [10].
For Rotavirus, cases were recorded from 1999 onwards but due to the workload to transfer
the huge number of records, it was interrupted a few years later (2002–2004). It was again initi-
ated in 2005 to obtain a background measurement of the number of diagnosed cases before the
introduction of 2 vaccines (Rotarix1 [GlaxoSmithKline Biologicals Rixensart, Belgium] in
June 2006 and RotaTeq1 [Merck&Co., Inc.Whitehouse Station, New Jersey] in June 2007)
[19]. The number of diagnosed Rotavirus cases decreased from 9414 cases in 2005 to 2359
cases in 2013, demonstrating the possibility of the network to follow-up the effect of the vac-
cine policy.
For RSV a continuous seasonal increase of cases was reported, starting every year from
week 40 i.e. at the beginning of October. The maximum number of cases per week is generally
situated at mid-December. The majority of the cases are diagnosed on young children of less
than 5 years. In 2013, 8294 cases were diagnosed by the network.
Representativity of the data
Although the geographical representativeness was previously investigated [9,10] we further
investigated whether all sentinel laboratories participated equally well for each pathogen.
Table 1 demonstrates the number of participating laboratories per pathogen in decreasing
order. Campylobacter was reported at median level over the 5 last years by 91 laboratories. Fur-
ther, Rotavirus and RSV, 2 pathogens introduced some years after the implementation of the
network were reported by respectively 82 and 74 participants.
Considering the respiratory infectious diseases RSV,M. pneumoniae, Adenovirus, and Para-
influenza virus, the number of reporting laboratories varied respectively with 74, 53, 41 and 17
(data not shown). This implicates that the cross pathogen comparison for symptomatic dis-
eases is hampered by the reporting participation of sentinel laboratories.
Discussion
There is an increasing need, both at national and international levels, to obtain epidemiological
information on many infectious diseases. We demonstrated here that the sentinel laboratory
30 Years of Surveillance of Infectious Diseases by the Sentinel Laboratory Network
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network is an important tool to provide the necessary data and thereby to accomplish these
tasks. It provides a robust surveillance for multiple infectious diseases in Belgium and this
despite some adaptations throughout these 30 years of the surveillance period. The most
important adaptations are: changes in diagnostic methodology by the advent of the PCR tech-
nology and the implementation of this sensitive technique to replace mainly the culture, struc-
tural reorganisations and fusions between clinical laboratories and the digital revolution, all
described in materials and methods. It has been implemented in Belgium since 1983 and was
since then one of the most important surveillance network in infectious diseases with a good
coverage demonstrating a good sensitivity and geographical representativeness [9, 10]. The col-
lection of a limited number of variables encourages approximately 58% of the available labora-
tories to voluntarily participate to this network. Whether this high participation rate of
laboratories reflects a similar coverage of the Belgian population was not assessed in this study
but was previously investigated [10].
During these 30 years of study, the surveillance system demonstrated also a great flexibil-
ity by having the capacity to monitor pathogens for the entire period (n = 10) while others
(n = 11) were added or removed depending of their public health needs. The longitudinal sur-
veillance of these pathogens was exemplified in the results section for some gastrointestinal
infectious diseases (Y. enterocolitica, Campylobacter and Rotavirus), sexually transmitted dis-
eases (Chlamydia trachomatis and N. gonorrhoeae), vaccine preventable diseases (N.menin-
gitidis, H. influenzae and Rotavirus) and the respiratory diseases (RSV). For all of these
pathogens we could demonstrate a surveillance which is in line with current international
findings [20].
For the vaccine preventable diseases, we could determine the impact of the introduction and
reimbursement of the vaccine policy (H. influenzae, N.meningitidis and Rotavirus). For Rota-
virus, it was previously demonstrated using the sentinel laboratory records that the infectious
season was delayed compared to pre-vaccination seasons [19].
We could demonstrate the effect of some environmental factors such as the dioxin affair
when during the summer period of 1999 the contamination of the feedstock resulted in the
destruction of massive amounts of animal food products [14]. Also during the same period less
animal food products such as eggs and poultry were consumed resulting in a decreased inci-
dence of Campylobacter infections [15].
Table 1. Overview of the number of sentinel laboratories reporting a particular infectious disease.
The indicated number of reporting laboratories is calculated from the median number of sentinel laboratories
reporting cases during the last 5 years of the study period.






S. pneumoniae 74 67–77
Y. enterocolitica 66 58–70
N. gonorrhoeae 64 61–67
S. pyogenes 53 51–59
M. pneumoniae 53 48–54
C. trachomatis 53 51–55
doi:10.1371/journal.pone.0160429.t001
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On the other hand the yearly increase in intensity of the seasonal peaks for RSV suggests for
an increased incidence during the winter period. No indications of shift of the seasonal peaks
neither a broadening of the curves were determined.
The huge increase in incidence of sexually transmitted infections (STI) during the last
decade is probably a reflection of the waning of prevention campaign. Why the incidence of
the different STI is different according to the gender and age group could not be unravelled by
the sentinel network due to the lack of clinical information. This observation is nevertheless
confirmed by data from other national networks [17].
We demonstrated as well that this network has the characteristic to be dynamic. This feature
is supported by the fact that it is possible to add a germ to the content of the recording at any
time in the course of the year. Therefore it requires a regular follow-up which is assured by the
scientific advice given by the yearly steering committee of the network bringing together the
sentinel laboratories, the reference centers, the epidemiologists and the sponsors of the net-
work. The addition of a pathogen as proposed by the steering committee can very easily be
added to the list and after informing the participating laboratories, data can be collected with-
out further investments in partners, infrastructure, or methodology of working.
It is also necessary to remain vigilant in continuing the surveillances even if a low incidence
is monitored. For instance the low burden of sexually transmitted infections during the 90’s
[21] was tempting to remove them from the list. Those years the decrease in incidence was a
profit from the massive prevention campaigns for HIV/AIDS. The continuous monitoring of
three main sexually transmitted infectious diseases demonstrates that monitoring even at low
burden remains important for the long term surveillance.
The roles of the reference centers are to confirm the diagnosis of the received samples and
to supply these with other invaluable microbial information, such as the type of circulating
strains at the human and/or food level or their sensibility towards antimicrobials. By collect-
ing and providing these microbial informations, the surveillance of particular pathogens is
further accomplished. As an example, the reference centers have shown the effect of the vac-
cination on the decrease of N.meningitidis, in particular the serogroup C present in the vac-
cine [18].
A high participation rate (more than 50%) was measured for 10 pathogens. However we
found different levels of participation for different infectious diseases belonging to the same
symptomatic disease. This is true for the respiratory infectious diseases, but is also true for the
gastrointestinal diseases and the sexually transmitted diseases (data not shown). This difference
in participation rate between pathogens hampers cross pathogen comparison for infectious dis-
eases belonging to the same symptomatic disease. By the implementation in the near future of
a new electronic data transfer system based on harmonized national coding standards and a
common data transfer route for all laboratories [22], the partial registration by some laborato-
ries will be overcome.
The advantage of the limited number of variables asked to the participating laboratories
makes it easier to stimulate them to participate. It allowed the monitoring of the epidemiology
in time and place. The drawback of this limited information is that no clinical information is
requested and thus no clinical surveillance can be provided.
In conclusion, the data supplied by this network represent a unique source of information
from the point of view of the public health. It allowed us to accurately detect and describe
trends, contribute to the estimation of the burden of disease and unravel the effect of the imple-
mentation of a vaccine policy or other events. These observations are currently presented in
pathogen specific reports and allow furthermore interesting comparisons with other national
and international information sources.
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